Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ference J Loupatty"'
Publikováno v:
Clinical chemistry. 62(11)
To the Editor: Hemodialysis patients are exposed to high amounts of phosphate and citrate, causing hypocalcaemia and hyperparathyroidism (1). These perturbations have a substantial role in extravascular calcifications causing cardiovascular disease a
Publikováno v:
Journal of Inherited Metabolic Disease
Journal of inherited metabolic disease, 35(1), 5-12. Springer Netherlands
Journal of inherited metabolic disease, 35(1), 5-12. Springer Netherlands
Valine is one of the three branched-chain amino acids which undergoes oxidation within mitochondria. In this paper, we describe the current state of knowledge with respect to the enzymology of the valine oxidation pathway and the different disorders
Autor:
Rob Ofman, Matthias R. Baumgartner, Seiji Yamaguchi, Annemarie van der Steen, Jos P.N. Ruiter, Ference J. Loupatty, Diana Ballhausen, Lodewijk IJlst, Ronald J.A. Wanders, Marinus Duran
Publikováno v:
Molecular Genetics and Metabolism, 87(3), 243-248. Academic Press
Molecular genetics and metabolism, 87(3), 243-248. Academic Press Inc.
Molecular genetics and metabolism, 87(3), 243-248. Academic Press Inc.
3-Hydroxyisobutyric aciduria is a rare entity and affected individuals display a range of clinical manifestations including dysmorphic features and neurodevelopmental problems in the majority of patients. Here, we present two novel patients with 3-hy
Autor:
Ronald J.A. Wanders, Carlo Dionisi-Vici, Gabriella Di Rosa, Enrico Bertini, Federica Deodato, Sara Boenzi, Andrea Maiorana, Giulia Tozzi, Adele D'Amico, Ference J. Loupatty, Filippo M. Santorelli, Cristiano Rizzo, Rosalba Carrozzo
Publikováno v:
Journal of inherited metabolic disease, 29(4), 546-550. Springer Netherlands
3-Methylglutaconic aciduria is the biochemical marker of several inherited metabolic diseases. Four types of 3-methylglutaconic aciduria can be distinguished. In the type I form, accumulation of 3-methylglutaconate is due to deficient activity of 3-m
Autor:
Ronald J.A. Wanders, Berry Kremer, Ference J. Loupatty, Udo F. H. Engelke, Marinette van der Graaf, Erik van den Bergh, Eva Morava, Leo A. J. Kluijtmans, Sandra Loss, Detlef Moskau, Ron A. Wevers
Publikováno v:
NMR in Biomedicine, 19, 2, pp. 271-8
NMR in Biomedicine, 19, 271-8
NMR in Biomedicine, 19, 271-8
Contains fulltext : 50036.pdf (Publisher’s version ) (Closed access) A diagnosis of 3-methylglutaconic aciduria type I (OMIM: 250950) based on elevated urinary excretion of 3-methylglutaconic acid (3MGA), 3-methylglutaric acid (3MG) and 3-hydroxyis
Publikováno v:
Clinical chemistry, 50(8), 1447-1450. American Association for Clinical Chemistry Inc.
3-Methylglutaconic aciduria (3MGA) type I (McKusick 250950) is biochemically characterized by increased excretion of 3-methylglutaconic acid, 3-methylglutaric acid, and 3-hydroxyisovaleric acid in urine. Affected individuals display a range of clinic
Autor:
Ference J. Loupatty, Lodewijk IJlst, Jos P.N. Ruiter, Marinus Duran, Willy Lehnert, Ronald J.A. Wanders
Publikováno v:
American journal of human genetics, 71(6), 1463-1466. Cell Press
American Journal of Human Genetics, 71(6), 1463-1466. Cell Press
American Journal of Human Genetics, 71(6), 1463-1466. Cell Press
3-Methylglutaconic aciduria type I is an autosomal recessive disorder clinically characterized by various symptoms ranging from delayed speech development to severe neurological handicap. This disorder is caused by a deficiency of 3-methylglutaconyl-
Autor:
Ilse van Stijn, Peter H. J. van der Voort, Berit Westra, Saskia Rijkenberg, Rob J. Bosman, Ference J Loupatty, Jos P.J. Wester, Inez-Anne Haagen
Publikováno v:
BMC Anesthesiology
Background The prognostic value of biochemical tests in critically ill patients with multiple organ failure and suspected bowel ischemia is unknown. Methods In a prospective observational cohort study intensive care patients were included when the at
Autor:
Ference J. Loupatty, Lianne S.M. Boesten, Annemieke C. Heijboer, Johannes M.W. van den Ouweland, Corinne C. Bekker, Marcel J.W. Janssen, Madelon M. Buijs, Jos P.M. Wielders, Frans A. L. Van Der Horst
Publikováno v:
Steroids, 77(13), 1366-1372. Elsevier Inc.
Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde, 37(3), 223-226. Nederlandse Vereniging voor Klinische Chemie
Janssen, M J W, Wielders, J P M, Bekker, C C, Boesten, L S M, Buijs, M M, Heijboer, A C, van der Horst, F A L, Loupatty, F J & van den Ouweland, J M W 2012, ' Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum ', Steroids, vol. 77, no. 13, pp. 1366-1372 . https://doi.org/10.1016/j.steroids.2012.07.013
Janssen, M J W, Wielders, J P M, Bekker, C C, Boesten, L S M, Buijs, M M, Heijboer, A C, Van Der Horst, F A L, Loupatty, F J & Van Den Ouweland, J M W 2012, ' Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum ', Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde, vol. 37, no. 3, pp. 223-226 .
Scopus-Elsevier
Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde, 37(3), 223-226. Nederlandse Vereniging voor Klinische Chemie
Janssen, M J W, Wielders, J P M, Bekker, C C, Boesten, L S M, Buijs, M M, Heijboer, A C, van der Horst, F A L, Loupatty, F J & van den Ouweland, J M W 2012, ' Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum ', Steroids, vol. 77, no. 13, pp. 1366-1372 . https://doi.org/10.1016/j.steroids.2012.07.013
Janssen, M J W, Wielders, J P M, Bekker, C C, Boesten, L S M, Buijs, M M, Heijboer, A C, Van Der Horst, F A L, Loupatty, F J & Van Den Ouweland, J M W 2012, ' Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum ', Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde, vol. 37, no. 3, pp. 223-226 .
Scopus-Elsevier
Measurement of serum 25-hydroxyvitamin D [25(OH)D] is generally considered to be a reliable indicator of vitamin D status. High variability in 25(OH)D measurements due to utilized test and assay technologies, non-equimolar detection of 25(OH)D2 and 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0ed5a6c6eb7c92fdfcc1c761fae3081
https://research.vumc.nl/en/publications/d07b4e54-2296-423c-a10e-130dfefbd47d
https://research.vumc.nl/en/publications/d07b4e54-2296-423c-a10e-130dfefbd47d
Autor:
Berry Kremer, A. Graham, Anibh M. Das, Michèl A.A.P. Willemsen, Eva Morava, Ron A. Wevers, S. Hogg, Sabine Illsinger, Leo A. J. Kluijtmans, Bridget Wilcken, Ronald J.A. Wanders, Saskia B. Wortmann, Johannes R.M. Cruysberg, Udo F. H. Engelke, Ference J. Loupatty
Publikováno v:
Neurology, 75(12), 1079-1083. Lippincott Williams and Wilkins
Neurology, 75, 12, pp. 1079-83
Neurology, 75(12), 1079-1083. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 75, 1079-83
Neurology, 75, 12, pp. 1079-83
Neurology, 75(12), 1079-1083. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 75, 1079-83
Contains fulltext : 89647.pdf (Publisher’s version ) (Closed access) OBJECTIVE: 3-Methylglutaconic aciduria type I is a rare inborn error of leucine catabolism. It is thought to present in childhood with nonspecific symptoms; it was even speculated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d6e73094760f4fa5712535fdc6aab5b
https://pure.amc.nl/en/publications/3methylglutaconic-aciduria-type-i-redefined-a-syndrome-with-lateonset-leukoencephalopathy(b75924eb-3fdf-4b17-8d0f-2c5f2d633b74).html
https://pure.amc.nl/en/publications/3methylglutaconic-aciduria-type-i-redefined-a-syndrome-with-lateonset-leukoencephalopathy(b75924eb-3fdf-4b17-8d0f-2c5f2d633b74).html